Global Maropitant Citrate Injectable Solution 麻豆原创 Growth 2025-2031

Publication ID:

LPI08256757

Publication Date:

August 11, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Maropitant Citrate Injectable Solution market size is predicted to grow from US$ 267 million in 2025 to US$ 402 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Maropitant Citrate Injectable Solution is a veterinary prescription medication commonly used in dogs and cats for the prevention and treatment of vomiting caused by various conditions, including motion sickness, gastroenteritis, and chemotherapy-induced nausea. Its active ingredient, maropitant, is a highly selective neurokinin-1 (NK1) receptor antagonist that works by inhibiting the action of substance P鈥攁 key neurotransmitter involved in the vomiting reflex鈥攂oth in the central and peripheral nervous systems. The injectable formulation is typically administered subcutaneously or intravenously, making it ideal for animals unable to take oral medications or in need of rapid symptom control. Known for its rapid onset and long duration of action (up to 24 hours), it is a widely used antiemetic in small animal practice. A leading commercial product is Cerenia庐, manufactured by Zoetis.
United States market for Maropitant Citrate Injectable Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Maropitant Citrate Injectable Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Maropitant Citrate Injectable Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Maropitant Citrate Injectable Solution players cover Zoetis, Dechra Vet Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淢aropitant Citrate Injectable Solution Industry Forecast鈥� looks at past sales and reviews total world Maropitant Citrate Injectable Solution sales in 2024, providing a comprehensive analysis by region and market sector of projected Maropitant Citrate Injectable Solution sales for 2025 through 2031. With Maropitant Citrate Injectable Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Maropitant Citrate Injectable Solution industry.
This Insight Report provides a comprehensive analysis of the global Maropitant Citrate Injectable Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Maropitant Citrate Injectable Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Maropitant Citrate Injectable Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Maropitant Citrate Injectable Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Maropitant Citrate Injectable Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Maropitant Citrate Injectable Solution market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
10ml Per Bottle
20ml Per Bottle
Segmentation by Application:
Canine
Feline
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zoetis
Dechra Vet Products
Key Questions Addressed in this Report
What is the 10-year outlook for the global Maropitant Citrate Injectable Solution market?
What factors are driving Maropitant Citrate Injectable Solution market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Maropitant Citrate Injectable Solution market opportunities vary by end market size?
How does Maropitant Citrate Injectable Solution break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Maropitant Citrate Injectable Solution Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Maropitant Citrate Injectable Solution by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Maropitant Citrate Injectable Solution by Country/Region, 2020, 2024 & 2031
2.2 Maropitant Citrate Injectable Solution Segment by Type
2.2.1 10ml Per Bottle
2.2.2 20ml Per Bottle
2.3 Maropitant Citrate Injectable Solution Sales by Type
2.3.1 Global Maropitant Citrate Injectable Solution Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Maropitant Citrate Injectable Solution Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Maropitant Citrate Injectable Solution Sale Price by Type (2020-2025)
2.4 Maropitant Citrate Injectable Solution Segment by Application
2.4.1 Canine
2.4.2 Feline
2.5 Maropitant Citrate Injectable Solution Sales by Application
2.5.1 Global Maropitant Citrate Injectable Solution Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Maropitant Citrate Injectable Solution Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Maropitant Citrate Injectable Solution Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Maropitant Citrate Injectable Solution Breakdown Data by Company
3.1.1 Global Maropitant Citrate Injectable Solution Annual Sales by Company (2020-2025)
3.1.2 Global Maropitant Citrate Injectable Solution Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Maropitant Citrate Injectable Solution Annual Revenue by Company (2020-2025)
3.2.1 Global Maropitant Citrate Injectable Solution Revenue by Company (2020-2025)
3.2.2 Global Maropitant Citrate Injectable Solution Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Maropitant Citrate Injectable Solution Sale Price by Company
3.4 Key Manufacturers Maropitant Citrate Injectable Solution Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Maropitant Citrate Injectable Solution Product Location Distribution
3.4.2 Players Maropitant Citrate Injectable Solution Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Maropitant Citrate Injectable Solution by Geographic Region
4.1 World Historic Maropitant Citrate Injectable Solution 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Maropitant Citrate Injectable Solution Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Maropitant Citrate Injectable Solution Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Maropitant Citrate Injectable Solution 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Maropitant Citrate Injectable Solution Annual Sales by Country/Region (2020-2025)
4.2.2 Global Maropitant Citrate Injectable Solution Annual Revenue by Country/Region (2020-2025)
4.3 Americas Maropitant Citrate Injectable Solution Sales Growth
4.4 APAC Maropitant Citrate Injectable Solution Sales Growth
4.5 Europe Maropitant Citrate Injectable Solution Sales Growth
4.6 Middle East & Africa Maropitant Citrate Injectable Solution Sales Growth
5 Americas
5.1 Americas Maropitant Citrate Injectable Solution Sales by Country
5.1.1 Americas Maropitant Citrate Injectable Solution Sales by Country (2020-2025)
5.1.2 Americas Maropitant Citrate Injectable Solution Revenue by Country (2020-2025)
5.2 Americas Maropitant Citrate Injectable Solution Sales by Type (2020-2025)
5.3 Americas Maropitant Citrate Injectable Solution Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Maropitant Citrate Injectable Solution Sales by Region
6.1.1 APAC Maropitant Citrate Injectable Solution Sales by Region (2020-2025)
6.1.2 APAC Maropitant Citrate Injectable Solution Revenue by Region (2020-2025)
6.2 APAC Maropitant Citrate Injectable Solution Sales by Type (2020-2025)
6.3 APAC Maropitant Citrate Injectable Solution Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Maropitant Citrate Injectable Solution by Country
7.1.1 Europe Maropitant Citrate Injectable Solution Sales by Country (2020-2025)
7.1.2 Europe Maropitant Citrate Injectable Solution Revenue by Country (2020-2025)
7.2 Europe Maropitant Citrate Injectable Solution Sales by Type (2020-2025)
7.3 Europe Maropitant Citrate Injectable Solution Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Maropitant Citrate Injectable Solution by Country
8.1.1 Middle East & Africa Maropitant Citrate Injectable Solution Sales by Country (2020-2025)
8.1.2 Middle East & Africa Maropitant Citrate Injectable Solution Revenue by Country (2020-2025)
8.2 Middle East & Africa Maropitant Citrate Injectable Solution Sales by Type (2020-2025)
8.3 Middle East & Africa Maropitant Citrate Injectable Solution Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Maropitant Citrate Injectable Solution
10.3 Manufacturing Process Analysis of Maropitant Citrate Injectable Solution
10.4 Industry Chain Structure of Maropitant Citrate Injectable Solution
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Maropitant Citrate Injectable Solution Distributors
11.3 Maropitant Citrate Injectable Solution Customer
12 World Forecast Review for Maropitant Citrate Injectable Solution by Geographic Region
12.1 Global Maropitant Citrate Injectable Solution 麻豆原创 Size Forecast by Region
12.1.1 Global Maropitant Citrate Injectable Solution Forecast by Region (2026-2031)
12.1.2 Global Maropitant Citrate Injectable Solution Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Maropitant Citrate Injectable Solution Forecast by Type (2026-2031)
12.7 Global Maropitant Citrate Injectable Solution Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Maropitant Citrate Injectable Solution Product Portfolios and Specifications
13.1.3 Zoetis Maropitant Citrate Injectable Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Dechra Vet Products
13.2.1 Dechra Vet Products Company Information
13.2.2 Dechra Vet Products Maropitant Citrate Injectable Solution Product Portfolios and Specifications
13.2.3 Dechra Vet Products Maropitant Citrate Injectable Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Dechra Vet Products Main Business Overview
13.2.5 Dechra Vet Products Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.